Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
Titel:
Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
Auteur:
Ungaro, Ryan C. Limketkai, Berkeley N. Jensen, Camilla Bjørn Yzet, Clara Allin, Kristine H. Agrawal, Manasi Ullman, Thomas Burisch, Johan Jess, Tine Colombel, Jean-Frederic